Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung CancerYan Xing, Jinhua Zhao, Gary Cook et al.|Journal of Nuclear Medicine|2019Cited by 164